AndrewTTurrisi IiiIIIMD

PubMed

• 109 citations
  Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline
  Charles B. Simone, Jeffrey A. Bogart, Alvin R. Cabrera, Megan E. Daly, Nicholas J. DeNunzio
  Practical Radiation Oncology. 2020-05-01
• 27 citations
  Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Data...
  Shaakir Hasan, Paul Renz, Andrew T. Turrisi, Athanasios Colonias, Gene Grant Finley
  Lung Cancer. 2018-08-20
• 2 citations
  Southwest Oncology Group: two decades of experience in non-small cell lung cancer.
  Andrew T. Turrisi, John Crowley, Kathy S. Albain, Laurie E. Gaspar, David R. Gandara
  Seminars in Oncology. 2005-04-01

Journal Articles

• Twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin etoposide: A randomized Intergroup stu...  
  Turrisi AT, Kim K, Blum R et al., New England Journal of Medicine, 1/1999
• Optic neuritis in nitrosoureas.  
  Louie AC, Turrisi AT, Muggia FM, Bono VH, Med and Ped Oncol 5:245-247
• Pulmonary toxicity after radiation and bleomycin: A review.  
  Catane R, Schwade JG, Turrisi AT, Webber BL, Muggia FM, Int J Rad Oncol Biol Phys 6:1513-1518
• Toxicity of WR-2721 administered in single and multiple doses.  
  Kligerman MM, Glover DJ, Turrisi AT, Norfleet AL, Yuhas JM, Coia LR, Simone C, Glick J, Goodman RL, Int J Rad Oncol Biol Phys 10:1773-1776
• A liquid chromatographic electrochemical assay for S-2-(3-aminopropylamino)ethylphosphorothioate (WR-2721) in human plasma.  
  Shaw LM, Bonner H, Turrisi AT, Norfleet AL, Glover DJ, J Liq Chrom 7:2447-2465
• Measurement of S-2-(3-aminopropylamino) ethanethiol (WR-1065) in blood and tissue.  
  Shaw LM, Bonner HS, Turrisi AT, Norfleet AL, Kligerman, MM, J Liq Chrom 9(4):845-859
• Phase I/II trials of WR-2721 and cis-Platinum.  
  Glover D, Glick JH, Weiler C, Fox K, Turrisi AT, Kligerman MM, Int J Rad Oncol Biol Phys 12:1509-1512
• Human pharmacokinetics of WR-2721.  
  Shaw LM, Turrisi AT, Glover DJ, Bonner HS, Norfleet AL, Weiler C, Kligerman MM, Int J Rad Oncol Biol Phys 12:1501-1504
• The final report of the phase I trial of single dose WR-2721 (S-2-(3-aminopropylamino)ethylphosphorothioic).  
  Turrisi AT, Glover DJ, Hurwitz S, Glick J, Norfleet AL, Weiler C, Yuhas JM, Kligerman MM, Ca Treat Rep 70(2):1389-1393
• Final report on Phase I trial of WR-2721 before protracted fractionated radiation therapy.  
  Kligerman MM, Turrisi AT, Urtasan RC, Norfleet AL, Phillips TL, Barkley T, Rubin P, Int J Rad Oncol Biol Phys 14:1110-1122
• The pharmacokinetics of WR-2721.  
  Shaw LM, Glover DJ, Turrisi AT, Brown D, Bonner H. Norfleet AL, Weiler C, Glick JH, Kligerman MM, Pharmac Ther 39:195-201
• Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy.  
  Glover D, Fox KR, Weiler C, Kligerman MM, Turrisi AT, Glick J, Pharmac Ther 39:3-7
• Invasive thymoma: The role of mediastinal irradiation following complete or incomplete surgical resection.  
  Curran WJ, Kornstein M, Brooks JJ, Turrisi AT, J Clin Oncol 6(11):1722-1727
• Palliative radiotherapy for metastatic malignant melanoma: Brain metastases, bone metastases and spinal cord compression.  
  Rate WR, Solin LJ, Turrisi AT, Int J Rad Oncol Biol Phys 15:859-864
• Cortical versus medullary thymomas: A useful morphologic distinction?  
  Kornstein MJ, Curran WJ, Turrisi AT, Brooks JJ, Human Pathology 19(11):1335-1339
• Management of CNS metastases in small cell lung cancer: A consensus report.  
  Pederson AG, Bishop JF, Bleehen NM, Earl H, Ettinger DS, Greco FA, Kristjansen PEG, Postmus PE, Turrisi AT, Lung Cancer 5:140-142
• Thoracic radiation therapy: Dosage and techniques.  
  Turrisi AT, Lung Cancer 5:248-253
• Adjuvant radiotherapy for recurrent granular cell tumor.  
  Rosenthal SA, LeVolsi VA, Turrisi AT, Cancer 65(4):897-900
• The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer.  
  Sandler HM, Curran WJ, Turrisi AT, Int J Rad Oncol Biol Phys 19:9-13
• Thoracic radiotherapy variables: Influence on local control in small cell lung cancer limited disease.  
  Turrisi AT, Glover DJ, Int J Radiat Oncol Biol Phys 19:1473-1479
• Pre-treatment minimal staging for non-small cell lung cancers: A consensus report.  
  Goldstraw P, Bureau G, Cullen M, Dabouis G, Deneffe G, Drings P, Turrisi A, Lung Cancer 7:7-9
• The relative benefit of concurrent radiotherapy with platinum etoposide for the treatment of limited small cell lung cancer.  
  Turrisi AT, Radiotherapie 79:411-414
• Innovations in multimodality therapy for lung cancer; combined modality management of limited small-cell lung cancer.  
  Turrisi AT, Chest 103(1):56S-59S
• The relative merits of altered fractionation in lung cancer with some emphasis in small cell lung cancer.  
  Turrisi AT, Lung Cancer 9:239-244
• Incorporation of radiotherapy fractionation in the combined modality treatment of limited small cell lung cancer.  
  Turrisi AT, Chest 103S(4):418S-422S
• Join now to see all

Books/Book Chapters

• Cancer Treatment. 
  Chapter: Non-Small Cell Lung Cancer 
  Page 598 - 628Figlin RA, Cameron RB, Turrisi ATEditors: Haskell C.WB Saunders, PhiladelphiaEdition 5th,
• Chemoradiation: an integrated approach to cancer treatment. 
  Chapter: Small-cell carcinoma of the lung 
  Page 347 - 360Turrisi AT, Johnson DH, Comis RLEditors: Madhu J. John, et. al.Lea & Febiger, PA
• Lung Cancer: Frontiers in Science and Treatment. 
  Chapter: Neoadjuvant therapy in locally advanced lung cancer: A perspective from radiation oncology 
  Page 645 - 655Hazuka MB, Turrisi ATEditors: Giovannia Motta. Grafica L.P.Genoa, Italy
• Cancer Treatment. 
  Chapter: Non-small cell lung cancer 
  Page 385 - 413Figlin RA, Holmes EC, Turrisi ATEditors: Haskell C.WB Saunders, Philadelphia
• Surgery of the Alimentary Tract, Vol I - The Esophagus. 
  Chapter: Radiation therapy in the treatment of carcinoma of the esophagus 
  Turrisi ATEditors: Zuidema GD, Orringer MB.W.B. Saunders, PhiladelphiaEdition 4th,
• Lung Cancer: Principles and Practice. 
  Chapter: Principles and Application of Preoperative and Standard Radiotherapy for Regionally Advanced Non-small Cell Lung Cancer 
  Sause WT and Turrisi ATEditors: Pass HI, Mitchell JB, Johnson DH, Turrisi AT.Lippincott-Raven, Philadelphia
• Lung Cancer Principles and Practice. 
  Chapter: Combined Modality Treatment for Locally Advanced Non-Small Cell Lung Cancer 
  Johnson DH, Turrisi AT, Pass HIEditors: Pass HI, Mitchell JB, Johnson DH and Turrisi AT eds.Lippincott-Raven, Philadelphia
• Lung Cancer. 
  Chapter: Radiation therapy: Its role in the treatment of limited disease small cell lung cancer 
  Page 128 - 135Turrisi ATArnold
• Radiation Injury, Advances in Management and Prevention.” Frontiers of Radiation Therapy and Oncology. 
  Chapter: Lung toxicity in the treatment of lung cancer: Thoughts at the end of the millennium 
  Page 63 - 70Thomas CR, Williams TE, Turrisi ATEditors: Meyer JL.Basel, Karger
• Clinical Radiation Oncology. 
  Chapter: Overview of Thoracic Oncology 
  Thomas CR, Turrisi ATEditors: Gunderson LL, Tepper JE.Churchill Livingston, New YorkEdition 1st,
• Lung Cancer: Principles and Practice. 
  Chapter: Combined Modality Treatment for Locally Advanced, Unresectable Non-Small Cell Lung Cancer 
  Page 910 - 920Johnson DH, Turrisi ATEditors: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JD.Lippincott Williams & Wilkins, PhiladelphiaEdition 2nd,
• Lung Cancer. 
  Chapter: Lung cancer: chemoradiotherapy options 
  Page 222 - 236Turrisi ATEditors: Jack A. Roth, James D Cox and Waun K. Hong.Blackwell Scientific Publications, Massachusetts
• Textbook of Clinical Oncology. 
  Chapter: Lung Cancer 
  Thomas CR, Williams TE, Cobos E, Turrisi ATEditors: Eyre HF, Lenhard RD Jr, Brady LW, Gansler T.American Cancer Society, AtlantaEdition 3rd,
• Controversies and Issues in Lung Cancer. 
  Chapter: Radiotherapy fractionation and volume issues in limited-stage small cell lung cancer 
  Williams TE, Thomas CR, Turrisi ATEditors: Movsas B, Langer CJ, Goldberg M.Marcel Dekker, New YorkEdition 1st,
• Diagnosis and Treatment of Lung Cancer: Updates. 
  Chapter: The Treatment of Limited Small Cell Lung Cancer: Progress and Future Promise 
  Turrisi AT, Sherman CAEditors: Detterbeck FC, Rivera MP, Socinski MA, Rosenman JG.WB Saunders Company Publishing
• 3-D Conformal and Intensity Modulated Radiation Therapy: Physics and Clinical Applications. 
  Chapter: New Frontiers in Radiation Oncology: A Physician’s Perspective 
  Page 603 - 612Turrisi ATEditors: Purdy JA, Grant WH, Palta JR, Butler EB, Perez CA. Advanced Medical Publishing
• The Respiratory Care Clinics of North America. 
  Chapter: The Role of Radiotherapy in the Treatment of Bronchogenic Carcinoma 
  Sherman CA, Turrisi AT, Silvestri GA, Bogart JWB Saunders
• Lung Cancer Principles and Practice. 
  Chapter: Multimodality therapy for limited-stage small cell lung cancer 
  Page 674 - 691Murray N, Erridge S, Turrisi ATEdition 3rd,
• Lung Cancer Principles and Practice. 
  Chapter: Radiotherapy for Locally Advanced Lung Cancer 
  Page 509 - 526Bogart JA, Turrisi ATEdition 3rd,
• Lung Cancer Principles and Practice. 
  Chapter: Combined chemotherapy and radiotherapy in locally advanced, unresectable non-small cell lung cancer 
  Page 617 - 625Corum L, Laskin J, Turrisi AT, Johnson DHEdition 3rd,
• Lung Cancer Principles and Practice. 
  Chapter: Multimodality therapy for limited-stage small cell lung caner; combining chemotherapy and radiotherapy 
  Erridge S, Murray N, Turrisi ATEdition 4th,
• The role of bleomycin in the treatment of advanced head and neck cancer. 
  Turrisi AT, Rozenzweig M. Von Hoff DD, Muggia FMEditors: Carter, Crooke and Umezawa.Academic Press, San Francisco
• Radioprotectors and Anticarcinogens. 
  Chapter: Experience with Phase I trials of WR-2721 preceding radiation therapy 
  Page 681 - 694Turrisi AT, Kligerman MM, Glick JH, Norfleet L, Gramkowski MEditors: O. Nygaard and M. Simic.Academic Press, New York
• Radioprotectors and Anticarcinogens. 
  Chapter: Clinical trials of WR-2721 with chemotherapy 
  Page 173 - 181Glick J, Glover DJ, Turrisi AT, Weiler C, Yuhas JM, Kligerman MMEditors: A. Breccia, CL Greenstock, M. Tamba.
• Advances on Oxygen Radicals and Radioprotectors. 
  Chapter: Clinical experiences with WR-2721 
  Page 173 - 181Kligerman MM, Glick J, Turrisi AT, Glover D, Norfleet L, Gramkowski MEditors: A. Breccia, CL Greenstock, M Tamba.
• Join now to see all

Abstracts/Posters

• A phase I-II study of daily carboplatin and simultaneous accelerated hyperfractionated chest irradiation followed by carboplatin in patients with regionally inoperable...
  Kelly K, Bunn PA, Hazuka M, Turrisi A, Lung Cancer 11(1):179
• Incidence and clinical significance of variant morphology (small cell/large cell subtype) in limited state small cell lung cancer (SCLC). A prospective analysis of an...
  Aisner SC, Turrisi AT, Kim KM, et al, Proceedings of ASCO Volume 17
• Observations after 5 year follow-up of intergroup trial 0096: 4 cycles of cisplatin (P) etoposide (E) and concurrent 45 Gy thoracic radiotherapy (TRT) given in daily ...
  Turrisi A, Kim K, Sause W, et al, Proceedings of ASCO, Volume 17
• A randomized study of CODE plus thoracic irradiation versus alternating CAV/EP for extensive stage small cell lung cancer (ESCLC).
  Murray N, Livingston R, Shepherd F, James K, Zee B, Langleben A, Kraut M, Bearden J, Goodwin J, Grafton C, Turrisi A, Walde D, Croft H, Ottaway J, Proceedings of ASCO Volume 16
• Concurrent Cisplatin/Etoposide Plus Radiotherapy (PE+RT) For Pathologic Stage (path TN) IIIB Non-Small Cell Lung Cancer (NSCLC): A Southwest Oncology Group (SWOG) Pha...
  Albain KS, Crowley JJ, Turrisi AT, Gandara DR, Farrar WB, Clark J, Beasley KR, Livingston RB, Proceedings of ASCO Volume 16
• A randomized trial comparing surgery (S) to preoperative concomitant chemoradiation plus surgery in patients (pts) with resectable esophageal cancer (CA).
  Urba S, Orringer M, Turrisi A, Whyte R, Iannettoni M, Forastiere A, Updated Analysis Proceedings of ASCO Volume 16
• Cisplatin (P) & Etoposide (E) + Thoracic Radiotherapy (TRT) Administered Once or Twice Daily (BID) In Limited Stage (LS) Small Cell Lung Cancer (SCLC): Final Report o...
  Johnson DH, Kim K, Sause W, Komaki R, Wagner H, Aisner S, Livingston R, Blum R, Turrisi AT, Proceedings of ASCO Vol. 15, Boston, MA
• Dose escalation for non-small cell lung cancer using conformal radiation therapy.
  Robertson JM, Turrisi AT, Hazuka MB, Martel MK, TenHaken RK, Littles JF, Martinez FJ, Lichter AS, Int J Radiat Oncol Biol Phys 32 (suppl 1): 197
• A randomized trial comparing transhiata esophagectomy (THE) to preoperative concurrent chemotherapy (CT) and radiotherapy (XRT) followed by esophagectomy in locoregion...
  Urba S, Orringer M, Turrisi A, Whyte R, Natale R, Forastiere A, Proc Amer Soc Clin Onc 14: 475
• Dose-escalation in non-small cell lung cancer (NSCLC) using conformal 3-dimensional radiation treatment planning (3DRTP): Preliminary results of phase I study.
  Hazuka MB, Turrisi AT, Martel MK, Ten Haken RK, Littles JF, Lichter AS, Fraass BA, Lung Cancer 11(1):137
• Preliminary analysis of a phase III trial in regionally advanced unresectable non-small cell lung cancer.
  Sause W, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran W, Byhardt R, Fisher B, Turrisi A, Lung Cancer 11(1):179
• Five-year results: Phase III trial of regionally advanced unresectable non-small cell lung cancer, RTOG 8808, ECOG 4588, SWOG 8992.
  Sause W, Kolesar P, Taylor S, Johnson D, Livingston R, Komaki R, Emani B, Curran W, Byhardt R, Fisher B, Turrisi A, Proceedings of ASCO Volume 17
• Estimation of tumor control probability model parameters from a database of 3-D dose distributions of non small cell lung cancer patients.
  Martel MK, TenHaken RK, Hazuka MB, Kessler ML, Turrisi AT, Fraass BA, Lung Cancer 11(1):183
• Endobronchial ultrasound-guided needle aspiration. An improved method for diagnosing intrathoracic lymphadenopathy.
  Shannon J, Becker F, Orens J, Bude R, Rubin J, Whyte R, Turrisi A, Martinez F, Lung Cancer 11(1):75
• Analysis of localization errors in the definition of the mantle field using a beam's-eye-view treatment planning system.
  Naida JD, Eisbruch A, Sandler HM, Turrisi AT, Schoeppel SL, Lichter AS, Int J Radiat Oncol Biol Phys 30 (suppl 1): 167
• Concurrent cisplatin/etoposide (PE) + chest radiation (CRT) followed by surgery for stages 3A(N2) and 3B non-small cell lung cancer: completed analysis of SWOG-8805.
  Albain K, Rusch V, Crowley J, Turrisi A, Rice T, Livingston R, Proceedings of Amer Soc Clin Oncol 13:337
• Re-irradiation of non-small cell lung cancer.
  Littles JF, Turrisi AT, Hazuka MB, Massey V, Martel M, Lung Cancer 11(1):139
• Daily (QD) v twice-daily (BID) thoracic irradiation (TI) with concurrent cisplatin-etoposide (PE) for limited small cell lung cancer (LSCLC). Preliminary Results on 3...
  Turrisi AT, Kim K, Johnson DH, Komaki R, Sause W, Curran W, Livingston R, Wagner H, Blum R, for the Eastern Cooperative Oncology Group, Lung Cancer 11(1):172
• Long term follow-up (F/U) from SWOG 8269: Concurrent cisPlatin (P), etoposide (E), Vincristine (V) and daily thoracic radiotherapy (TRT) for the treatment of limited ...
  Turrisi AT, Rector D, Janaki LM, McCracken JD, Livingston R, Giri SP, Gordon W, Crowley J, from the Southwest Oncology Group, Lung Cancer 11(1):172
• Cisplatin (P) & etoposide (E) + concurrent thoracic radiotherapy (TRT) administered once versus twice daily for limited-stage (LS) small cell lung cancer (SCLC): Prel...
  Johnson DH, Kim K, Turrisi AT, Sause W, Wagner H, Blum R, for the Eastern Cooperative Oncology Group, Proceedings of Amer Soc Clin Oncol 13:333
• Patterns of failure and second malignancies from SWOG-8269: concurrent cisplatin (P), etoposide (E), vincristine (V), and once daily radiotherapy (RT) for the treatme...
  Janaki L, Rector D, Turrisi A, McCracken J, Livingston R, Giri S, Gordon W, Crowley J, for the Southwest Oncology Group, Proceedings of Amer Soc Clin Oncol 13:331
• Conformal high-dose external radiation therapy (CHERT) alone for medically inoperable non-small cell lung cancer (MILC).
  Urbanic JJ, Turrisi A, Sharma A, Silvestri G, Nietert P, Williams T, Vanek K, Sherman C, Harley R, ASCO Meeting
• Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
  Johnson DH, Rusch VW, Turrisi, AT, J Natl Cancer Inst; 99(6):415-8
• Postoperative radiotherapy in resected non-small-cell lung cancer: every creek has two banks.
  Johnson DH, Turrisi A, Current Oncology Reports. 2(1):51-3
• Based on long experience, what brings the future in radiotherapy for lung cancer?
  Turrisi AT, J Thorac Oncol; 6 (suppl 2): S136 (M27.3)
• Join now to see all

Lectures

• The Role of Radiation Therapy in Lung Cancer (Small Cell and Non-Small Cell). 
  Lung Cancer Task Force, European School of Oncology, Venice, Italy
• Combined Modality Therapy and Cranial Irradiation in Small Cell Lung Cancer. 
  European School of Oncology, Venice, Italy
• Radiotherapy for Non-Small Cell Lung Cancer: Role in Surgical Adjuvant and Regional Disease. 
  European School of Oncology, Venice, Italy
• Combined Chemotherapy and Irradiation for Limited SCLC. 
  US/Japan Joint Seminar on Lung Cancer, Okayama, Japan
• The Role of Hyperfractionated Thoracic Radiotherapy in the Treatment of Lung Cancer (Small Cell and Non-Small Cell). 
  American Thoracic Society and the International Union against Tuberculosis, Boston, MA
• Limited small cell lung cancer (LSCLC): Concurrent BID thoracicradiotherapy (TRT) with Platinum-Etoposide (PE): An ECOG Study. 
  ASCO, Washington, DC
• Concurrent twice daily thoracic radiotherapy (BID-TRT) and Platinum-Etoposide (PE) chemotherapy in limited small cell lung cancer (LSCLC). 
  Second International Conference on Small Cell Lung Cancer, Milano Marittima, Italy
• Prophylactic cranial irradiation (PCI) given at completion of systemic therapy for LSCLC: Analysis of long term follow-up. 
  Second International Conference on Small Cell Lung Cancer, Milano Marittima, Italy
• Radiotherapy for Early Stage Hodgkin's Disease. 
  Joint Annual Scientific Meeting and Exhibition, Dublin, Ireland
• The Relative Benefit of Concurrent Radiotherapy with Platinum Etoposide for the Treatment of Limited Small Cell Lung Cancer. 
  Centre Leon Berard, Radiation Oncology Department, Lyon, Cedex, France
• Concurrent Radiotherapy. 
  Third International Conference on Small Cell Lung Cancer, Ravenna, Italy
• Management of Non-Small Cell Lung Cancer. 
  International Congress of Radiation Oncology (ICRO '93), Kyoto, Japan
• Current Concepts for Locally Advanced Non-small Cell Lung Cancer and the Prospect of 3-D Treatment Planning. 
  Cross Cancer Institute, Edmonton, Alberta, Canada
• Multimodality Therapy for Thoracic Neoplasms-Is this the Gold Standard? 
  American College of Chest Physicians, Annual International Scientific Assembly, New Orleans, LA
• Peter MacCallum New Developments in Oncology. 
  Symposium, Melbourne, Australia
• Small Cell Lung Cancer. 
  2nd ASTRO Spring Program, Chicago, IL
• Lung Cancer – Management Controversies. 
  ASCO, Philadelphia, PA
• Controversies in Staging and Combined Treatment Modalities in Lung Cancer. 
  Meeting, Brussels, Belgium
• Combined Chemoradiotherapy in Lung Cancer. 
  Thai Society of Radiation Oncology Bangkok, Thailand
• Recent Progress and Future Directions in the Treatment of Lung Cancer. 
  Osaka, Japan
• Surgery and other methods for local control in lung cancer. 
  5th Central European Lung Cancer Conference in Prague, Czech
• Evolving Trends in the Treatment of Unresected Lung Cancer: Facts and Future Prospects. 
  Multiple locations, 1998
• Cancer of the Esophagus – Modern Trends in Non-Operative Management. 
  SASMO Conference, Cape Town, South Africa
• Lung Paper. 
  SASMO Conference, Cape Town, South Africa
• Small Cell and Other Lung Issues. 
  ASCO, Los Angeles, CA
• Join now to see all